iPatientCare EHR v2014 (2.0) receives SureScripts Certification for Electronic Prescribing of Controlled Substances Services

Share Article

iPatientCare EHR v2014 (2.0) software is afforded certification for the Surescripts Implementation Guide v 10.6 2013-05-01, EPCS Services, and Connectivity to Surescripts through HTTPS with Basic Authentication

iPatientCare EHR v2014 (2.0) receives SureScripts Certification for Electronic Prescribing of Controlled Substances Services
Revalidating NEWRX, REFREQ, REFRES, STATUS, ERROR with respect to Surescripts 10.6 Routing Implementation Guide v 2013-05-01, and also validating connectivity to Surescripts through HTTPS with Basic Authentication. - Shripal Shah, STO, iPatientCare, Inc.

iPatientCare, Inc., a pioneer in mHealth and cloud-based ambulatory EHR and integrated Practice Management solutions announced today that it is now certified for the electronic prescribing of controlled substances (EPCS) services and also other prescription routing messages against the most recent ePrescribing implementation standards. With this added certification, iPatientCare prescribers would have complete end-to-end ePrescribing capabilities as part of their awards-winning, easy-to-use, Cloud-based EHR.

Electronic prescribing has high potential for improving the efficiency and cost-effectiveness of prescription transactions while improving the quality of patient care. Prescriptions for controlled substances were not permitted to be transmitted electronically until recently. For EPCS, particular attention from Provider organizations is required to undergo identity proofing, issuance of two-factor authentication credentials, setting of logical access control to EPCS applications, and their EHR with EPCS functionality must undergo a “third-party audit”.

“Adding EPCS functionality to our own ePrescribing module within iPatientCare EHR was a project by itself because of the time and effort required for the DEA audit, implementing two-factor authentication, revalidating NEWRX, REFREQ, REFRES, STATUS, ERROR with respect to Surescripts 10.6 Routing Implementation Guide v 2013-05-01, and also validating connectivity to Surescripts through HTTPS with Basic Authentication. Achieving these goals successfully is a great achievement of iPatientCare’s engineering team.”, said Shripal Shah, Sr. Technology Officer, iPatientCare.

Udayan Mandavia, CEO, iPatientCare commented cheerfully, “Although, the NY State has postponed to implement the requirement that all prescriptions issued in the state—including those for controlled substances—be transmitted electronically until March 27, 2016, iPatientCare stands committed even today to offer complete ePrescribing capabilities including the controlled substances. We believe, this is a significant achievement of iPatientCare and that is as per its long track-record of being a high achiever and thought-leader in this space that has been persistently demanding improvement in patient care and curbing of prescription fraud and abuse. ”

It is obvious that, if prescribers and pharmacies in New York are going to be able to take full advantage of the breathing room afforded by the postponement of EPCS implementation in the State of NY, all ePrescribing vendors and Provider organizations must continue to work very diligently to prepare for this somewhat delayed, but still looming, legal mandate.

About iPatientCare:

iPatientCare, Inc. is a privately held medical informatics company based at Woodbridge, New Jersey. The company is known for its pioneering contribution to mHealth and Cloud based unified product suite that include Electronic Health/Medical Record and integrated Practice Management/Billing System, Patient Portal/PHR, Health Information Exchange (HIE), and mobile point-of-care solutions that serve the ambulatory, acute/sub acute, emergency and home health market segments.

iPatientCare EHR 2014 (2.0) has received 2014 Edition Ambulatory Complete EHR certification by ICSA Labs, an Office of the National Coordinator-Authorized Certification Body (ONC-ACB), in accordance with the applicable eligible professional certification criteria adopted by the Secretary of Health and Human Services (HHS).

Full certification details can be found at ONC Certified Health IT Product List.

The ONC 2014 Edition criteria support both Stage 1 and 2 Meaningful Use measures required to qualify eligible providers and hospitals for funding under the American Recovery and Reinvestment Act (ARRA).

iPatientCare’s ONC 2014 Edition Meaningful Use Stage 2 Certified Complete EHR is also Designated as a Test EHR by CMS.

The company has won numerous awards for its EHR technology and is recognized as an innovator in the field, being a pioneer to offer an EHR technology on a handheld device, an innovative First Responder technology to the US Army for its Theatre Medical Information System, the first to offer a Cloud based EHR product. iPatientCare is recognized as one of the best EHR and Integrated PM System for small and medium sized physicians’ offices; has been awarded most number of industry Awards; and has been recognized as a preferred/MU partner by numerous Regional Extension Centers (REC), hospitals/health systems, and academies.

Visit http://www.iPatientCare.com for more information.

Contact:
iPatientCare, Inc.
One Woodbridge Center, Suite 812, Woodbridge, New Jersey 07095
Phone: 800-741-0981 | Fax: 732.676.7667 | Email: info(at)ipatientcare(dot)com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Udayan Mandavia
@iPatientCareEHR
Follow >
iPatientCare, Inc.
Like >
iPatientCare, Inc.

Follow us on
Visit website